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Conceptual issues
In 1944 Hans Asperger, an Austrian pediatrician,
writing in German, described four boys aged between
6 and 11 years who had come to his attention because
of difficulties relating to their peers ([3] translated in
[28]). Unknown to him, a child psychiatrist working
at Johns Hopkins in Baltimore, Leo Kanner, described
11 children with similar impairments of social inter-
action, communication and behavior the previous
year, and coined the term infantile autism’ [44].
Wing [103] essentially introduced Asperger’s syn-
drome to the English speaking scientific community
when she described 34 cases, aged between 5 and
35 years, who had a clinical presentation similar to
Asperger’s account. Wing, however, proposed some
modifications to the syndrome based on her cases.
For example, although Asperger thought the condi-
tion unrecognizable prior to 3 years of age, Wing
suggested that difficulties were present in the first
2 years of life, including the absence of imaginative
play and speech abnormalities. Wing also noted the
similarities between autism and Asperger syndrome
(AS). However, although most researchers have
drawn close parallels between AS and autism, arguing
for the existence of a continuum, the autism spectrum
disorders (ASDs) [104], the relationship between AS
and autism remains unresolved, as will be discussed
subsequently [45, 46, 61, 109].
Before its introduction in the ICD-10 [110] and
DSM-IV [1], AS tended to be conceptualized as either
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j Abstract Asperger syndrome
(AS) is a chronic neurodevelop-
mental disorder of social interac-
tion, communication, and a
restricted range of behaviors or
interests. Although not generally
associated with intellectual dis-
ability, the severe social disability
and, in many cases, associated
mental health and other medical
problems, result in disability
throughout life. The diagnosis is
often delayed, sometimes into
adulthood, which is unfortunate
because there are now a range of
interventions available, and the
current evidence supports inter-
vention starting as early in child-
hood as possible. The aim of this
review is to present a description
of AS, an up to date synopsis of
the literature pertaining to its
etiology, co-morbidity and inter-
vention options, and a discussion
of current nosological controver-
sies.
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(1) a mild form of autism, (2) a manifestation of aut-
ism in people of normal intellectual ability, (3) a
higher verbally functioning form of autism, or (4) a
socially motivated’ form of autism. To complicate
things, several different diagnostic criteria had been
proposed. Its inclusion in ICD-10 and DSM-IV was
intended to provide a set of criteria to overcome this
problem. In the field trial conducted as part of DSM-IV
and ICD-10 cases with clinical diagnoses of Asperger
disorder were noted to differ BOTH from those with
autism (e.g., in terms of verbal-performance IQ profile
and increased rates of unusual circumscribed interests
in AS cases) and those with pervasive developmental
disorders not otherwise specified (PDD-NOS), with
significantly greater severity of social difficulties in
cases of AS [99]. Although offering the possibility of a
single set of criteria that allow data across studies to be
compared, the result has, unfortunately, been simply
to change rather than solve the conceptual problems.
When AS was introduced in the ICD-10 and DSM-
IV it was placed alongside autism as a pervasive
developmental disorder, sharing the same criteria
with autism, but differing in terms of its apparently
normal cognitive functioning and language develop-
ment, the onset’ rule, and on the basis of a number of
communicative impairments that are present in aut-
ism but absent from AS. In addition, autism auto-
matically takes priority in the diagnostic hierarchy
(the precedence’ rule). However, it has been argued
that because of these onset and precedence rules’,
diagnosing AS becomes a near impossibility [52, 58],
and the diagnosis is tilted’ towards autism on the
basis of vague developmental phenomena rather than
on real empirical data concerning developmental
pathways to social disability [109]. In addition, in
view of the fact that they share’ diagnostic criteria,
the study of the differentiation of AS vis-a`-vis autism
has become problematic and tautological, and,
therefore, it is no surprise that most research supports
a relationship between them, and examination of
external validity thus becomes meaningless.
It is important for the classification debate to move
beyond the current arguments concerning the rela-
tionship between autism and AS, and instead examine
the external validity of more sophisticated opera-
tionalised criteria. Several different models are pos-
sible, based on the absence or presence of early
language impairments, or based on active but odd’
versus socially aloof’ groupings for example. At the
current time, the strongest evidence for external
validity is when a definition closer to Asperger’s
description is used [46], as emphasized in the text
revision of the DSM-IV, but, sadly, not incorporated
into its diagnostic criteria.
Another related nosological uncertainty is the
internal validity of AS. As discussed subsequently,
both ICD-10 and DSM-IV have de-emphasized the
communication impairment in favor of the social and
behavioral features. This is unfortunate, as Asperger,
Wing and others have argued that they are common
and an essential feature. What is also unclear, how-
ever, is whether people with AS differ from one an-
other because of differences in severity of symptoms,
or whether there are subgroups’ according to differ-
ent phenotypic features, such as communication fea-
tures, or pattern of ritualistic behaviors [29, 73, 82,
86]. The results have failed to reach any consensus.
Whilst a number of studies have shown that people
with AS differ according to a severity gradient [73,
86], others have shown evidence for subtypes [29, 82],
which is also reflected in everyday clinical practice,
where wide variation in symptomatology is seen. It is
important to clarify this from both a nosological and
genetic point of view.
Clinical characteristics
Most experts agree that impairment of reciprocal
social interaction is the sine qua non of both AS and
autism [95]. People with AS are typically motivated to
interact with others, but find themselves socially iso-
lated because of their odd communication style [45,
95, 103], which is often overly formal and may take
the form of an in-depth monologue about a topic of
special interest regardless of whether their interlocu-
tor is interested or not. As Asperger originally
emphasized, these are children who talk before they
walk’ and words are their lifeline’—a stark contract
to autism where speech is typically delayed and usu-
ally not a source of great strength. In AS speech is
often verbose and tangential. There may also be
peculiarities to the speech itself [45, 95, 103]. For
example, it may lack the normal prosody and may
also be odd in terms of volume, rate or rhythm.
Sometimes pauses reflect the difficulties people with
AS have in formulating answers to questions and
structuring their discourse. As previously indicated,
these pragmatic language impairments were unfor-
tunately de-emphasized in the DSM-IV and ICD-10.
People with AS often engage in restricted and
repetitive patterns of behavior [45, 95, 103]. Whilst
these are categorized in both ICD-10 and DSM-IV as
being of four different types, they can be usefully
conceptualized as lower level’ (including stereotyped
motor movements) and higher level’ (including rit-
uals and circumscribed interests). Among people with
AS, these behaviors are more likely to manifest as
resistance to change in a personal routine or in their
immediate environment, or with the pursuit of a
circumscribed interest. Such interests are generally
focussed on amassing large amounts of information
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on a particular topic, and typically, will take up a large
amount of the individual’s time, and take precedence
over other activities. This intensity easily differenti-
ates such interests from those of their peers. Impor-
tantly, such interests take precedence over social
activities with peers, and interaction’ with others may
take the form of one-sided talk about their interest.
What is also notable is that there is an increased
engagement in such interests with age, and they can
be debilitating in terms of frequency of engagement as
well as degree of distress that they cause the person
and their family [85].
A recent retrospective analysis of cases seen by
Asperger indicated that of the 44 with detailed
information, 82% clearly had special circumscribed
interests [41]. The nature of the interest was men-
tioned for 33 cases, allowing categorization. A whole
range of interests were represented, including animals
and nature (N = 10), scientific interests (N = 9), and
collecting facts (N = 8), and more rarely hobbies that
could not be classified such as a fascination with
puns, Mickey Mouse and national socialism.
Diagnostic methods
Currently, the gold standard diagnostic approach is to
use clinical judgment combined with a combination
of the autism diagnostic interview revised (ADI-R)
[55] and autism diagnostic observation scale (ADOS)
[54]. The ADI-R is a semi-structured interview with a
primary caregiver, while the ADOS is a semi-struc-
tured play/interactive session. Both require specific
training in administration. Both have algorithms for
ICD-10 and DSM-IV diagnoses of autism, and also
allow diagnosis of AS to be made based upon the
precedence and onset rules discussed above. An
alternative widely used semi-structured diagnostic
instrument is the diagnostic interview for social and
communication disorders (DISCO) [105]. A number
of other instruments are available, specifically de-
signed to be used where a diagnosis of AS is queried.
These include screening instruments (ASQ [12], AQ
[8], ASSQ [22]) and diagnostic instruments (ASDS
[64], GADS [36], ASDI [35]). Most of these have data
on validity and reliability and are commercially
available. As with any standardized diagnostic tool,
they do not replace good clinical judgment.
Co-morbidities
Most of the research on co-morbidities in PDDs has
focussed on autism [31, 50, 111]. However, there is
also consistent evidence that AS is associated with an
increased prevalence of certain mental health prob-
lems [47, 103], in particular depression [34] and
anxiety [90, 92], as well as certain medical problems,
notably seizures and sleep problems [23], and other
developmental disorders, namely Tourette’s syn-
drome [7] and ADHD [34]. Unfortunately, many of
these studies are based on psychiatric clinic samples,
and diagnoses have been given according to clinical
judgment rather than standardized measures, and
further research in this area is needed. This not-
withstanding, in the meantime it seems reasonable to
conclude that co-morbidity is relatively common.
Differential diagnosis: related concepts
A number of other diagnostic labels have been used,
and continue to be used, to describe people of normal
intellectual ability who have difficulties with social
interaction and communication. These include non-
verbal learning disability from neuropsychology [75],
schizoid personality from child psychotherapy [106,
107] and right hemisphere learning disability from
child neurology [20, 101]. However, AS is the only
term used in the current volumes of the DSM-IV and
ICD-10.
What is unclear is whether these are fundamentally
different syndromes or labels evolved from different
areas of clinical expertise describing what is funda-
mentally the same syndrome. The term schizoid
personality of childhood was coined by Wolff to de-
scribe a group of children whose clinical phenotype,
whilst similar to Asperger’s, was characterized by (1)
prominent conduct disorder, (2) better adult adjust-
ment, and (3) a slight increased risk of schizophrenia.
In contrast nonverbal learning disabilities (NLD)
([75] and for recent review see [76]) is used to de-
scribe individuals with social and communicative
difficulties who have a significant verbal/performance
discrepancy favoring the former. Finally, the term
developmental learning disabilities of the right
hemisphere (DLDRH) [101] has been used to describe
a cluster of symptoms that were associated with
damage to the right side of the brain. Whilst there is
little doubt that DLDRH is synonymous with NLD,
and AS is synonymous with Wolff’s cases, the rela-
tionship beyond this needs further clarification.
The relationship between AS and obsessive–com-
pulsive symptoms (including obsessive–compulsive
disorder (OCD) and, among adults, obsessive–com-
pulsive personality disorder) is also not entirely clear,
and the differential diagnosis can sometimes be dif-
ficult. In most instances of AS, however, the repetitive
patterns of behavior, in particular the pursuit of cir-
cumscribed interests, are often associated with plea-
sure and mastery rather than egodystonicity. Even so,
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the similarities between these disorders may suggest a
more fundamental relationship [11], which requires
further exploration.
Epidemiology
Ehlers and Gillberg [21], using their own diagnostic
criteria, found a point prevalence of 28.5/10,000 (95%
CI 0.6–56.5/10,000) for AS. Examining six other
studies that ascertained the prevalence of AS alongside
autism [26, 27] leads to a median prevalence estimate
of 2.6/10,000. Of particular note is that these surveys
consistently found the rates of AS to be lower than
autism, with autism on average five times as common
as AS (median prevalence for autism 13/10,000).
Etiology
j Genetic studies
There is now compelling evidence from family and
twin studies for a genetic basis for autism ([4, 13, 25,
89]. The early work is summarized by Pericak-Vance
[67]). Unfortunately, there is a paucity of studies
specifically examining families of probands with AS.
Asperger identified similar traits in family members
of his patients, particularly among fathers, suggesting
genetic factors were important. In addition, two
studies have investigated genetic risk in relatives of
AS probands. Volkmar and colleagues [96] presented
data on 99 families of probands with AS, which
demonstrated a strong family history of AS among
first-degree relatives, and evidence of a genetic rela-
tionship between autism and AS. Ghaziuddin [30]
came to similar conclusions.
For people with autism, the strongest support for
linkage is on 2q [15, 43, 83] and 7q [16, 43, 84],
particularly for people with phrase speech delay [14,
15, 83], but with evidence of linkage also starting to
coalesce in other chromosomal areas (see Veenstra-
VanderWeele et al. [94] for the most recent summary
of linkage findings). Numerous genes have been
investigated for possible candidacy, but there have
been no consistently replicated findings.
Although these same genetic risk factors may be
relevant for AS, there is a paucity of linkage and
association studies specifically examining probands
with AS. Indeed, at the time of writing only one study
has investigated genetic linkage in AS [112], and two
cytogenetic studies mapped breakpoints [2, 93]. Yl-
isaukko-oja [112] examined 17 multiplex families
with 119 affected probands, 72 of whom fulfilled the
ICD-10 criteria for AS, and the remainder of whom
had Asperger-like features but did not fulfill all
diagnostic criteria. Linkage was observed at 1q21-22,
3p14-24 and 13q31-33. Interestingly, the loci on
chromosomes 1 and 3 overlap with previously iden-
tified autism susceptibility loci, and on 1 and 13, with
schizophrenia susceptibility loci. In contrast the two
cytogenetic studies describe three different individu-
als with breakpoints involving the short arm of
chromosome 17, at 17p13. Whilst strongly suggesting
genes disrupted by this breakpoint may be responsi-
ble for the phenotype, candidate genes were not
identified. Moreover, this chromosomal locus has not
been previously identified by linkage strategies.
The male:female ratio of at least 9:1 for AS suggests
that male specific genes might be involved in the
phenotypic expression of this disorder. Stone and
colleagues [88] examined patterns of linkage in 148
multiplex families obtained from the autism genetic
resource exchange (AGRE), and found enhanced
linkage for the male only group at 17q, suggesting this
susceptibility region may be important for the AS
group. Moreover, samples stratified according to the
presence of repetitive patterns of behavior also result
in increased linkage to this region, particularly rele-
vant in view of the prominence of such symptoms in
the clinical phenotype of AS, whereby the presence of
circumscribed interests is necessary for the diagnosis.
j Neuropsychological studies
The neuropsychological literature on autism is vast,
but broadly speaking falls into one of three areas: that
pertaining to (1) theory of mind [5], (2) executive
function [40] or (3) central coherence [37]. Briefly,
individuals with AS relative to their age and IQ mat-
ched general population peers have been shown to
have (1) difficulties passing’ theory of mind tasks, (2)
executive dysfunction and (3) a tendency to interpret
visual stimuli in parts rather than wholes, so-called
poor central coherence. These neuropsychological
findings are similar to those observed among people
with autism. Importantly, however, some studies have
found that people with AS are relatively intact on
theory of mind [113] and EF [72], providing some
support, along with the findings on intellectual tests
described below, for the external validity of AS vis-a`-
vis autistic disorder.
In addition, other neuropsychological literature
that has examined patterns of performance on tests of
intellectual and more general abilities concluded that
autism is characterized by a PIQ > VIQ profile,
whilst AS, a VIQ > PIQ profile [53]. This latter pat-
tern of strengths on verbal skills relative to visuo-
spatial skills and non-verbal problem solving
characterizes nonverbal learning disability, a term
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coined to describe individuals with socio-communi-
cative impairments who have this particular pattern
of cognitive strength and weakness. There is indeed
strong support from neuropsychological studies for
an association between AS and NLD [76]. Emphasis is
placed on the right hemisphere as underlying the
clinical and neuropsychological presentation of these
two disorders, although, as will become apparent in
the following section, a number of different neuro-
anatomical sites are implicated in autism and AS.
j Neuroimaging studies
Several neuroanatomical regions of the brain have been
implicated, including frontal lobe and temporal lobe
regions, and the amygdala, but most studies have been
probands with autism. Whilst a number of postmortem
studies of people with autism implicated cerebellar
abnormalities [9, 10, 18, 19], more recent research
using MRI has failed to find any such abnormalities
among people with autism, AS, and PDDNOS [80].
The studies which included people with AS dem-
onstrated, along with their autism counterparts,
abnormal patterns of activation’ in the inferior tem-
poral sulcus [78, 79], and areas of frontal dysactiva-
tion during the performance of neuropsychological
tests [24, 38, 62, 74]. Other studies of AS probands
have also demonstrated abnormality of functional
integration of the amygdala and parahippocampal
gyrus [102], and structural abnormalities of the infe-
rior temporal gyrus, entorhinal cortex and rostral
fusiform gyrus [49].
A father and son both with AS and near identical
areas of cortical dysmorphology have also been de-
scribed [97]. In both, MRI scanning demonstrated a
region of missing tissue in each hemisphere at the
point at which the middle frontal gyrus intersects with
the precentral sulcus. In another case report an 11-
year-old boy is described with a lesion in the right
middle temporal gyrus white matter [98].
Megalencephaly remains a consistent finding among
people with autism [51, 100], although no study has
investigated brain size specifically among people with
AS. However, interestingly, males are known to have
larger brains than females, and there has been a sug-
gestion that ASDs, and AS in particular, may be ex-
plained by an extreme male brain’ phenotype [6].
Management
j Behavioral and educational interventions
These are used to (1) develop social skills, (2)
encourage adaptive problem solving strategies and
reduce maladaptive patterns of behavior, and (3)
teach more effective communication. Although not
based on strong empirical evidence, their by and large
ecologically valid approach and widespread use, with
a handful of anecdotal single case reports, lends
support to their effectiveness. In general the approach
is based on using the child’s strengths (typically ver-
bal cognitive ability and nonsocial language skills) to
address areas of weakness (nonverbal and social
problem solving and pragmatic language). Although a
detailed account of behavioral approaches is beyond
the scope of the current review, certain themes
dominate. These are summarized as follows:
j Educational programs should be tailored accord-
ing to each individual’s pattern of cognitive
strengths and vulnerabilities, as evidenced by their
profile on neuropsychological tests:
j Rote verbal learning of social rules’ may be more
effective than learning by role-playing or pictori-
ally administered stimuli.
j A parts to whole’ approach should be used, where
the verbal information is presented as a series of
steps, rather than a narrative gestalt.
j Most people with AS will cope better in small
classes with the option for 1:1 supervision and
support and small group activities.
j As far as possible, children with AS should be inte-
grated with their normotypical peers from whom
they can generalize the social and communicative
skills they learn during the more structured sessions.
j The curriculum may need to be adapted for the
child with AS, in terms of, for example, allowing
more time to complete tasks, making certain
instructions have been understood, etc.
j Adaptive skills should be taught explicitly by, for
example, scheduling, practicing and rehearsing.
Areas of vulnerability can be identified from scores
on the Vineland adaptive behavior scale (VABS).
j Organizational skills, often an area of vulnerability
as a result of poor executive function, can be tar-
geted by, for example, the use of scheduling,
scripts, rules or lists (things to do’).
j Social skills and pragmatic language training, usu-
ally delivered in the form of a group, refers to a
variety of widely used approaches that include fo-
cussed instruction on actual target behaviors (such
as, for example, eye contact), training in social
perception, as provided by computer packages such
as Let’s Face It, or Mind Reading: An Interactive
Guide to Human Emotions, and allowing the
opportunity to practice the skills they have learned
in varied, naturalistic contexts for generalization
and maintenance (for a more detailed account see
[48, 66]).
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j Psychopharmacological interventions
There are a number of symptoms that commonly
occur among people with AS that may be responsive
to particular pharmacologic interventions. In the ab-
sence of a strong base of evidence it seems reasonable
to assume that people with AS will show a similar
response as their general population counterparts.
Nonetheless, people with AS may be more sensitive to
the effects of psychotropics, and it is sensible to start
with low doses, monitor change, and titrate slowly to
the most effective dose.
Inattention/hyperactivity Hyperactivity and inat-
tention are common in AS [34]. Psychostimulants,
such as methylphenidate, and selective noradrenergic
reuptake inhibitors, such as atomoxetine, are used to
treat ADHD. In children and adolescents with autism,
Asperger’s syndrome or PDDNOS there is evidence
for the efficacy of methylphenidate [70], although
among people with PDDs there is a risk of higher
rates of steretypies, tics, social withdrawal and stim-
ulant-induced psychosis in conjunction with their use
[77]. There is also some evidence to support the
usefulness of atomoxetine for treating ADHD symp-
toms in children with autistic disorder [39].
Rigidity In the general population, certain selective
serotonin reuptake inhibitors (SSRIs) have the
strongest evidence of efficacy in the treatment of
symptoms of repetitive thoughts and ritualistic pat-
terns of behavior diagnosed as OCD. Although there
are no clinical trials establishing the efficacy of these
in treating such symptoms in people with AS, a few
studies, specifically of children and adults with aut-
ism, have demonstrated efficacy for the SSRI Flu-
voxamine [60] and the SSRI Fluoxetine [17], although
Fluvoxamine resulted in serious side effects among
children with autism [60], including hyperactivity and
irritability, which was avoided in a subsequent study
by employing a lower starting dose and less steep
titration [56].
Irritability and aggression A number of treatment
options have proven effective in the treatment of these
symptoms in people with autism. These include the
SSRIs Fluvoxamine [60] (but note caution discussed
in previous section) and the SSRI Sertraline [59, 87],
the novel serotonin and noradrenaline reuptake
inhibitor (SNRI) Mirtazapine [68], and the atypical
antipsychotic risperidine [69]. Of note, the studies of
McDougle [59] and Posey [68] both included subsets
with AS.
Depression A number of studies have demonstrated
the high rates of depression among people with AS
[34, 47, 91, 103]. In the general population, several
groups of drugs are used to treat depression, most
notably the SSRIs. Although there are no clinical trials
establishing the efficacy of antidepressants in people
with AS, there is no reason to believe that these
compounds would be less efficacious in AS than the
general population. A few studies specifically of chil-
dren and adults with autism have demonstrated effi-
cacy for Fluoxetine [33], Citalopram [65], and
Mirtazapine [68] (an SNRI). Of note, the study of
Posey et al. also included subjects with AS and
PDDNOS.
Anxiety Anxiety is also common among people
with AS. In the general population, several groups of
drugs are used to treat anxiety, most notably the
SSRIs, Buspirone and b-blockers. Although there are
no clinical trials establishing the efficacy of these in
people with AS, there is no reason to believe that these
compounds would be less efficacious in this group
than the general population. A few studies specifically
of children and adults with autism have demonstrated
efficacy for Citalopram [65], Fluvoxamine [71], Ser-
traline [87] and Mirtazapine [68].
Studies of outcome
There is now some evidence that as many as 20% grow
out’ of their disorder, failing to meet the diagnostic
criteria in adulthood [81], while many others improve’
[81]. What is not clear is what factors predict those
these differing outcomes. In contrast, other studies of
outcome have investigated social adjustment, in terms
of employment, opportunities and friendship. By far
the most informative studies are longitudinal in design
that measure outcome and its predictors and corre-
lates, and there are now several studies that focus
exclusively on people with autism with IQs in the
normal range [42, 57], which indicate that although the
majority improve over time, difficulties, in terms of
communication skills, social adjustment and inde-
pendent living, continue into adulthood.
A small body of literature also purports an asso-
ciation between AS and criminal offending’ [63]. This
evidence’ is limited, however, as the majority of these
are single case studies or case series, and do not,
therefore, inform on the vast majority of people with
AS who live in the community, who are probably no
more likely to come into contact with the criminal
justice system as perpetrators than their general
population counterparts [32, 108].
Future directions
Although the relationship between autism and AS
remains an important area of research, it will only be
useful if current nosological conceptualizations are
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modified. Moving away from the assumption that
Asperger’s is simply a subtype’ of autism may pro-
vide a better basis for external validity. The text
revision of the DSM-IV has begun to recognize some
of the more characteristic symptoms of AS, and recent
research has started to investigate external validity
based upon modified criteria [46]. Nosological re-
search such as this is urgently needed, and will form
the basis for emerging conceptualizations of AS, its
underlying etiology, and its relationship to other
disorders of social interaction, including autism,
schizoid PD and NLD.
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